SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Kopran Ltd

BSE: 524280 NSE: KOPRAN ISIN: INE082A01010
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Kopran Ltd belong to?
Kopran Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Kopran Ltd a good quality company?
Kopran Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is Kopran Ltd undervalued or overvalued?
Kopran Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is Kopran Ltd a good buy now?
Kopran Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Kopran Ltd?
Kopran Ltd revenue growth is -19.7% for FY-2025 , which is below its 5 year CAGR of 8.6% , indicating slower growth.
Q.2 Gross Profit margin of Kopran Ltd?
Kopran Ltd Gross profit margin which is the profit after deduction of direct costs, is 15.1% for FY-2025 , which is in line with its 5 year median of 15.1% , indicating stable margins.
Q.3 Operating Profit Margin of Kopran Ltd?
Kopran Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 14.26% for FY-2025 , which is above its 5 year median of 10.93% indicating increasing margins.
Q.4 Net Profit Margin of Kopran Ltd?
Kopran Ltd Net Profit Margin is 9.91% for FY-2025 , is below with its 5 year median of 10.26%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 15.1 15.1
Operating Profit Margin 14.26 10.93
Net Profit Margin 9.91 10.26
Q.5 Return on Asset of Kopran Ltd?
Kopran Ltd Return on Asset is 5.08%, which is below its 5 year historical median of 6.44%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Kopran Ltd?
Kopran Ltd Return on equity is 6.35% for FY-2025 , which is below its historical median of 8.07%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Kopran Ltd?
Kopran Ltd Return on capital employed is 8.63% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Kopran Ltd?
Kopran Ltd Cash conversion cycle is 110 days, above its historical median of 82 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.51 0.56
ROE 6.35 8.07
ROCE 8.63 9.44
Cash Conversion Cycle 110 days 82 days
Q.9 Debt to Equity ratio of Kopran Ltd?
Kopran Ltd Debt-to-Equity ratio is 0.11 , which is lower with the industry average of 0.15 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Kopran Ltd?
Kopran Ltd Debt to cash flow from operations is 1.94 , which is at a moderate level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Kopran Ltd?
Promoters hold 44.42% of the Kopran Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Kopran Ltd vs industry peers?
Kopran Ltd revenue CAGR is 8.61% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 271 137.1
Gross Profit 40.9 15.1
Operating Profit 39 16
Net Profit 27 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.51 0.8
ROE 6.35 8.91
ROCE 8.63 11.59
Cash Conversion Cycle (days) 110.19 76

Valuation & price assessment

Q.1 Stock return of Kopran Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 11.8% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 11.8% 5.5% 3.3% -21.7%
Q.3 Valuation ratios of Kopran Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 36.93 20.20 40.28
Price to Book 1.75 1.35 2.77
Price to Sales 2.84 1.60 2.65
EV to EBITDA 21.07 11.40 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×